The latest news from academia, regulators
research labs and other things of interest
Posted: October 4, 2008
CombiMatrix to Discuss Development of its Array for Cancer Screening
(Nanowerk News) CombiMatrix Corporation will hold a conference call to discuss the development of its CombiMatrix Cancer Array (CCA) test for cancer screening.
Dr. Amit Kumar, President and CEO of CombiMatrix will host this call and will make a short presentation, followed by Q&A. The CCA test is a cancer screening product with multi-billion dollar market potential. This product is in the R&D pipeline of CombiMatrix. This presentation will provide information about the product, its current development stage, its market potential, and other relevant information.
The presentation will start at 2 p.m. Pacific Time (5 p.m. Eastern) on Tuesday, October 7, 2008. To attend the conference call, dial the access number 1-800-868-1837 for domestic callers and 1-404-920-6604 for direct dial or international callers. Enter the Conference Code 85329577 followed by the # sign (85329577#). To view the slide presentation concurrently with the conference call click on the following link (or copy it to your URL): https://www.accuconference.com/customer/join/. Enter the Conference Code 85329577 and click ``Join.''
The live call, including the slide presentation, may also be accessed on CombiMatrix's website at http://www.combimatrix.com, in the Investor/Events section, where playback will be available for 30 days beginning October 8, 2008.